Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun 3;26(6):1099-1108.
doi: 10.1093/neuonc/noad259.

Cluster-based prognostication in glioblastoma: Unveiling heterogeneity based on diffusion and perfusion similarities

Affiliations

Cluster-based prognostication in glioblastoma: Unveiling heterogeneity based on diffusion and perfusion similarities

Martha Foltyn-Dumitru et al. Neuro Oncol. .

Abstract

Background: While the association between diffusion and perfusion magnetic resonance imaging (MRI) and survival in glioblastoma is established, prognostic models for patients are lacking. This study employed clustering of functional imaging to identify distinct functional phenotypes in untreated glioblastomas, assessing their prognostic significance for overall survival.

Methods: A total of 289 patients with glioblastoma who underwent preoperative multimodal MR imaging were included. Mean values of apparent diffusion coefficient normalized relative cerebral blood volume and relative cerebral blood flow were calculated for different tumor compartments and the entire tumor. Distinct imaging patterns were identified using partition around medoids (PAM) clustering on the training dataset, and their ability to predict overall survival was assessed. Additionally, tree-based machine-learning models were trained to ascertain the significance of features pertaining to cluster membership.

Results: Using the training dataset (231/289) we identified 2 stable imaging phenotypes through PAM clustering with significantly different overall survival (OS). Validation in an independent test set revealed a high-risk group with a median OS of 10.2 months and a low-risk group with a median OS of 26.6 months (P = 0.012). Patients in the low-risk cluster had high diffusion and low perfusion values throughout, while the high-risk cluster displayed the reverse pattern. Including cluster membership in all multivariate Cox regression analyses improved performance (P ≤ 0.004 each).

Conclusions: Our research demonstrates that data-driven clustering can identify clinically relevant, distinct imaging phenotypes, highlighting the potential role of diffusion, and perfusion MRI in predicting survival rates of glioblastoma patients.

Keywords: diffusion; glioblastoma; machine learning; perfusion; prognostic biomarker.

PubMed Disclaimer

Conflict of interest statement

None declared.

Figures

Figure 1.
Figure 1.
Graphical representation of the study structure. Only the training set was used to calculate cutoffs, for clustering and model training. The test dataset was used as a holdout dataset to provide an unbiased evaluation of the final model.
Figure 2.
Figure 2.
Percentages of high imaging parameters within the 2 clusters in the different tumor compartments. Cluster 1 shows a significantly higher percentage of patients with high diffusion values in all compartments, whereas cluster 2 shows higher perfusion values in all compartments (chi-tests, P-value after Bonferroni correction < 0.001).
Figure 3.
Figure 3.
Kaplan–Meier plots of OS in the training data set (A) and test data set (B), stratified to low or high-risk groups according to clustering. Significance was calculated using the log-rank test.

Similar articles

Cited by

References

    1. Aquilanti E, Miller J, Santagata S, Cahill DP, Brastianos PK.. Updates in prognostic markers for gliomas. Neuro Oncol. 2018;20(suppl_7):viivii17–viivii26. - PMC - PubMed
    1. Poon MTC, Sudlow CLM, Figueroa JD, Brennan PM.. Longer-term (>/= 2 years) survival in patients with glioblastoma in population-based studies pre- and post-2005: a systematic review and meta-analysis. Sci Rep. 2020;10(1):11622. - PMC - PubMed
    1. Ellingson BM, Bendszus M, Boxerman J, et al.; Jumpstarting Brain Tumor Drug Development Coalition Imaging Standardization Steering Committee. Consensus recommendations for a standardized brain tumor imaging protocol in clinical trials. Neuro Oncol. 2015;17(9):1188–1198. - PMC - PubMed
    1. van Dijken BRJ, van Laar PJ, Smits M, et al.. Perfusion MRI in treatment evaluation of glioblastomas: clinical relevance of current and future techniques. J Magn Reson Imaging. 2019;49(1):11–22. - PMC - PubMed
    1. Anzalone N, Castellano A, Cadioli M, et al.. Brain gliomas: multicenter standardized assessment of dynamic contrast-enhanced and dynamic susceptibility contrast MR Images. Radiology. 2018;287(3):933–943. - PubMed

Publication types